HB 275 Medicare Prescription Drug Price Negotiation Act of 2019
US Congress 116th Congress
Medicare Prescription Drug Price Negotiation Act of 2019
HB-275
About HB-275
Requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
HB-275: Medicare Prescription Drug Price Negotiation Act of 2019